Representative multiplex IHC staining revealed a higher number of double-positive CD3+PD-1+ T cells residing in the tumor in the control group compared with the anti–IL-1β–treated CC-LR mice (Supplemental Figure 4A). The gene discussed is IL1B; the disease is neoplasm.